Pricing Log in Create free account

Celldex Therapeutics, Inc. (CLDX) vs Fortrea Holdings Inc. (FTRE)

Celldex Therapeutics, Inc. and Fortrea Holdings Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Fortrea Holdings Inc. are of similar size ($2.3B and $2.2B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −2.09% against −88.3%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −33,883.8%) and the lower return on invested capital (−0.48% vs 0.00%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 11 and Celldex Therapeutics, Inc. on 7.

Valuation

Metric CLDX FTRE Biotechnology median
P/E n/m n/m 8.50
P/S 2,415.94 0.80 9.71
P/B 3.00 4.07 2.13
Price to free cash flow n/m 10.77 20.82
EV/EBITDA n/m 44.71 0.64
EV/Sales 1,609.78 1.13 9.21
Earnings yield (15.80%) (4.05%) (33.15%)
Free cash flow yield (11.30%) 9.29% (25.50%)

Profitability

Metric CLDX FTRE Biotechnology median
Gross margin 100.00% 19.30% 65.16%
Operating margin (36,733.82%) (0.40%) 0.00%
Net margin (33,883.77%) (3.18%) 0.00%
Free cash flow margin (27,294.81%) 7.40% 0.00%
Return on equity (43.88%) (15.30%) (56.36%)
Return on assets (40.76%) (3.07%) (48.04%)
Return on invested capital 0.00% (0.48%) 0.00%

Growth

Metric CLDX FTRE Biotechnology median
Revenue growth (TTM) (88.27%) (2.09%) 6.02%
EPS growth (last fiscal year) (59.18%) (194.55%) 30.26%
Revenue growth, 5-year CAGR (26.93%) 1.09% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLDX FTRE Biotechnology median
Debt to equity 0.00 2.01 0.00
Current ratio 11.82 0.96 4.72
Net debt to EBITDA 1.78 266.13 0.96

Dividend

Metric CLDX FTRE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLDX FTRE Biotechnology median
Market cap 2.27b 2.16b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack